Lehrstuhl für Innere Medizin V

CAR T-Cell Therapy in Autoimmune Disease. Reply. (2024) Müller F, Mackensen A, Schett G Journal article, Letter CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis (2024) Krickau T, Naumann-Bartsch N, Aigner M, Kharboutli S, Kretschmann S, Spörl S, Vasova I, et al. Journal article Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries (2024) Lübke J, Christen D, Schwaab J, Kaiser A, Naumann N, Shoumariyeh K, Jentzsch M, et al. Journal article Efficacy of Subperiosteal Drains in Chronic Subdural Hematoma: A Prospective Randomized Single-Center Study (2024) Bozhkov Y, Feulner J, Buchfelder M, Kleiß MA, Brandner S, Kinfe TM Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab. (2024) Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, et al. Journal article Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders (2024) Mougiakakos D, Sengupta R, Gold R, Schroers R, Haghikia A, Lorente M, Pendleton M, et al. Journal article Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply. (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kretschmann S, Atzinger A, et al. Journal article Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients (2024) Rios CA, Qayed M, Etra AM, Reshef R, Newcomb R, Yuhasz N, Hexner EO, et al. Journal article Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers. (2024) Fischer-Riepe L, Kailayangiri S, Zimmermann K, Pfeifer R, Aigner M, Altvater B, Kretschmann S, et al. Journal article